<p><em>基于证据的风险评估工具实现 40% 的增长，医疗机构优先考虑通过个性化筛查进行早期检测</em></p>
<p>, /PRNewswire/ -- Ikonopedia，乳腺影像报告和跟踪解决方案的领导者，今天宣布其风险意识™产品的采用显著增长。这是一种基于网络的 Tyrer-Cuzick 乳腺癌风险评估工具，专为放射科实践和乳腺健康提供者设计。自 2023 年推出以来，Ikonopedia 的风险意识™已被超过 50 家医疗机构采用，截至 2025 年第三季度，代表着新客户年初至今超过 40% 的增长。</p>
<p>新采用者包括 BeSound、Mammoth Hospital、Snoqualmie Valley Health、Alameda Health System、Optum Health、Evans Memorial Hospital、Color Health、Premier Health Oncology，以及国际合作伙伴瑞士纳沙泰尔的 Cabinet Cavenaghi - Faivre-Mayor 和越南的 FV Hospital。</p>
<p>&#34;我们很高兴看到如此多的放射科团队、医院和健康系统接受风险意识，将个性化乳腺癌风险评估直接融入他们的护理模式，&#34;Ikonopedia 的总裁兼首席执行官 Emily Crane 表示。&#34;赋予女性个性化的风险信息可以导致更早的检测和更好的结果。这是我们使命的核心——让乳腺健康工具对每位患者和提供者都可及、高效且有意义。&#34;</p>
<p><strong>为什么这很重要</strong></p>
<p>根据美国癌症协会的数据，乳腺癌仍然是美国女性中最常被诊断的癌症，也是美国女性癌症死亡的第二大原因。1 在全球范围内，它是最常被诊断的癌症，也是女性癌症死亡的主要原因。2</p>
<p>Tyrer-Cuzick 模型是估算女性一生乳腺癌风险的最全面和广泛使用的工具之一。3 它整合了一系列风险因素，包括家族史和 BRCA 等基因突变、乳腺密度、BMI、 reproductive 和激素变量、良性乳腺疾病，并在筛查人群中进行了广泛的验证。</p>
<p>&#34;我们的使命是为乳腺护理带来舒适、清晰和准确，而 Ikonopedia 的风险意识使我们能够主动为患者提供更深入的乳腺癌风险因素见解，&#34;BeSound 的创始人兼首席执行官 Bailey Renger 表示。&#34;通过整合风险意识 API，我们已将 Tyrer-Cuzick 风险评估无缝地纳入我们的系统和工作流程中，确保提供流畅而全面的患者护理体验。&#34;</p>
<p>将这一基于证据的模型纳入放射科工作流程，使临床医生能够识别可能受益于增强监测的患者，包括 MRI 筛查、基因咨询或早期乳腺 X 光检查。</p>
<p>正如 Ikonopedia 的医疗顾问、前 Intermountain Health 乳腺影像医学主任 Brett T. Parkinson 博士在产品发布时所指出的：</p>
<p>&#34;使乳腺影像中心能够向患者提供 Tyrer-Cuzick 风险评估在早期检测乳腺癌方面具有变革性意义。&#34;</p>
<p><strong>使风险评估成为常规</strong></p>
<p>Ikonopedia 的风险意识™为放射科和乳腺健康实践提供了一个经过许可的基于网络的 Tyrer-Cuzick 评估工具版本，可以集成到患者门户或在现场使用。这种可及性确保更多女性能够主动评估自己的风险，并获得个性化的后续护理建议。</p>
<p>&#34;乳腺健康风险评估不应是特权——它应该是患者护理的标准部分，&#34;Crane 补充道。&#34;风险意识帮助每个实践，无论规模大小，提供这种主动和定制的基于证据的护理水平。&#34;</p>
<p><strong>关于 Ikonopedia Inc.</strong></p>
<p>Ikonopedia Inc.是乳腺影像报告和跟踪解决方案的领导者，提供创新的基于云的软件，旨在提高乳腺影像的效率和准确性。Ikonopedia 由著名的乳腺放射科医生创立，致力于通过先进的技术和以患者为中心的方法提升患者护理。了解更多信息，请访问 www.ikonopedia.com。</p>
<p>参考文献：</p>
<ol>
<li>https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/cancer-facts/cancer-facts-for-women.html</li>
<li>Bray F 等。2022 年全球癌症统计：GLOBOCAN 对 185 个国家 36 种癌症的发病率和死亡率估计。CA Cancer J Clin. 2024 年 5-6 月;74(3):229-263. doi: 10.3322/caac.21834. Epub2024 年 4 月 4 日。PMID: 38572751。</li>
<li>https://www.nationalbreastcancer.org/blog/tyrer-cuzick-model/</li>
</ol>
<p>来源 Ikonopedia</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REEyNjQ5NiZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcxNjIzUFJfTkVXU19VU1BSX19fX19EQTI2NDk2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REEyNjQ5NiZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcxNjIzUFJfTkVXU19VU1BSX19fX19EQTI2NDk2"/></p>

<p>Ikonopedia 宣布其 Risk Aware™ 产品的采用显著增长，这是一款基于网络的乳腺癌风险评估工具。自 2023 年推出以来，已有超过 50 家医疗机构采用该工具，增长率达到 40%。该工具整合了 Tyrer-Cuzick 模型，帮助早期检测和个性化护理。Ikonopedia 旨在使乳腺健康工具变得可及且高效，通过主动风险评估提升患者护理</p>

<p><em>Evidence-Based Risk Assessment Tool Achieves 40% Growth as Healthcare Organizations Prioritize Early Detection Through Personalized Screening</em></p>
<div class="lb-trans"><p><em>基于证据的风险评估工具实现 40% 的增长，医疗机构优先考虑通过个性化筛查进行早期检测</em></p>
</div><p>, /PRNewswire/ -- Ikonopedia, a leader in breast imaging reporting and tracking solutions, today announced significant growth in adoption of its Risk Aware™ product, a web-based Tyrer-Cuzick Breast Cancer Risk Assessment tool designed for radiology practices and breast health providers. Since launching in 2023, Risk Aware™ by Ikonopedia has been adopted by more than 50 healthcare organizations through Q3 2025, representing over 40% year-to-date growth in new customers.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Ikonopedia，乳腺影像报告和跟踪解决方案的领导者，今天宣布其风险意识™产品的采用显著增长。这是一种基于网络的 Tyrer-Cuzick 乳腺癌风险评估工具，专为放射科实践和乳腺健康提供者设计。自 2023 年推出以来，Ikonopedia 的风险意识™已被超过 50 家医疗机构采用，截至 2025 年第三季度，代表着新客户年初至今超过 40% 的增长。</p>
</div><p>New adopters include BeSound, Mammoth Hospital, Snoqualmie Valley Health, Alameda Health System, Optum Health, Evans Memorial Hospital, Color Health, Premier Health Oncology, and international partners Cabinet Cavenaghi - Faivre-Mayor in Neuchâtel, Switzerland and FV Hospital in Vietnam.</p>
<div class="lb-trans"><p>新采用者包括 BeSound、Mammoth Hospital、Snoqualmie Valley Health、Alameda Health System、Optum Health、Evans Memorial Hospital、Color Health、Premier Health Oncology，以及国际合作伙伴瑞士纳沙泰尔的 Cabinet Cavenaghi - Faivre-Mayor 和越南的 FV Hospital。</p>
</div><p>&#34;We're thrilled to see so many radiology groups, hospitals, and health systems embracing Risk Aware to bring personalized breast cancer risk assessment directly into their care models,&#34; said Emily Crane, President and CEO of Ikonopedia. &#34;Empowering women with personalized risk information leads to earlier detection and better outcomes. That's the heart of our mission—to make breast health tools accessible, efficient, and meaningful for every patient and provider.&#34;</p>
<div class="lb-trans"><p>&#34;我们很高兴看到如此多的放射科团队、医院和健康系统接受风险意识，将个性化乳腺癌风险评估直接融入他们的护理模式，&#34;Ikonopedia 的总裁兼首席执行官 Emily Crane 表示。&#34;赋予女性个性化的风险信息可以导致更早的检测和更好的结果。这是我们使命的核心——让乳腺健康工具对每位患者和提供者都可及、高效且有意义。&#34;</p>
</div><p><strong>Why It Matters</strong></p>
<div class="lb-trans"><p><strong>为什么这很重要</strong></p>
</div><p>According to the American Cancer Society, breast cancer remains the most commonly diagnosed cancer among U.S. women and the second leading cause of cancer death in U.S. women.1 Worldwide, it is the most commonly diagnosed cancer and the leading cause of cancer death among women.2</p>
<div class="lb-trans"><p>根据美国癌症协会的数据，乳腺癌仍然是美国女性中最常被诊断的癌症，也是美国女性癌症死亡的第二大原因。1 在全球范围内，它是最常被诊断的癌症，也是女性癌症死亡的主要原因。2</p>
</div><p>The Tyrer‑Cuzick model is one of the most comprehensive and widely used tools for estimating a woman's lifetime breast cancer risk.3 It integrates a broad set of risk-factors, including family history and genetic mutations such as BRCA, breast density, BMI, reproductive and hormonal variables, benign breast disease—and has undergone extensive validation in screening populations.</p>
<div class="lb-trans"><p>Tyrer-Cuzick 模型是估算女性一生乳腺癌风险的最全面和广泛使用的工具之一。3 它整合了一系列风险因素，包括家族史和 BRCA 等基因突变、乳腺密度、BMI、 reproductive 和激素变量、良性乳腺疾病，并在筛查人群中进行了广泛的验证。</p>
</div><p>&#34;Our mission is to bring comfort, clarity, and accuracy to breast care, and Ikonopedia's Risk Aware enables us to proactively provide our patients with deeper insights into their breast cancer risk factors,&#34; said Bailey Renger, Founder &amp; CEO of BeSound. &#34;By integrating the Risk Aware API, we've seamlessly incorporated the Tyrer-Cuzick risk assessment into our systems and workflow, ensuring a streamlined and comprehensive patient care experience.&#34;</p>
<div class="lb-trans"><p>&#34;我们的使命是为乳腺护理带来舒适、清晰和准确，而 Ikonopedia 的风险意识使我们能够主动为患者提供更深入的乳腺癌风险因素见解，&#34;BeSound 的创始人兼首席执行官 Bailey Renger 表示。&#34;通过整合风险意识 API，我们已将 Tyrer-Cuzick 风险评估无缝地纳入我们的系统和工作流程中，确保提供流畅而全面的患者护理体验。&#34;</p>
</div><p>Incorporating this evidence-based model into radiology workflows enables clinicians to identify patients who may benefit from enhanced surveillance, including MRI screening, genetic counseling, or early mammography.</p>
<div class="lb-trans"><p>将这一基于证据的模型纳入放射科工作流程，使临床医生能够识别可能受益于增强监测的患者，包括 MRI 筛查、基因咨询或早期乳腺 X 光检查。</p>
</div><p>As Dr. Brett T. Parkinson, Ikonopedia medical advisor and former Medical Director of Breast Imaging at Intermountain Health, noted at the product's launch:</p>
<div class="lb-trans"><p>正如 Ikonopedia 的医疗顾问、前 Intermountain Health 乳腺影像医学主任 Brett T. Parkinson 博士在产品发布时所指出的：</p>
</div><p>&#34;Enabling breast imaging centers to offer the Tyrer-Cuzick risk assessment to their patients is game-changing in detecting breast cancer early.&#34;</p>
<div class="lb-trans"><p>&#34;使乳腺影像中心能够向患者提供 Tyrer-Cuzick 风险评估在早期检测乳腺癌方面具有变革性意义。&#34;</p>
</div><p><strong>Making Risk Assessment Routine</strong></p>
<div class="lb-trans"><p><strong>使风险评估成为常规</strong></p>
</div><p>Risk Aware™ by Ikonopedia provides radiology and breast health practices with a licensed, web-based version of the Tyrer-Cuzick assessment tool that can be integrated into patient portals or used onsite. This accessibility ensures more women can proactively assess their risk and receive personalized recommendations for follow-up care.</p>
<div class="lb-trans"><p>Ikonopedia 的风险意识™为放射科和乳腺健康实践提供了一个经过许可的基于网络的 Tyrer-Cuzick 评估工具版本，可以集成到患者门户或在现场使用。这种可及性确保更多女性能够主动评估自己的风险，并获得个性化的后续护理建议。</p>
</div><p>&#34;Breast health risk assessment should not be a privilege—it should be a standard part of patient care,&#34; added Crane. &#34;Risk Aware helps every practice, regardless of size, deliver that level of proactive and customized evidence-based care.&#34;</p>
<div class="lb-trans"><p>&#34;乳腺健康风险评估不应是特权——它应该是患者护理的标准部分，&#34;Crane 补充道。&#34;风险意识帮助每个实践，无论规模大小，提供这种主动和定制的基于证据的护理水平。&#34;</p>
</div><p><strong>About Ikonopedia Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Ikonopedia Inc.</strong></p>
</div><p>Ikonopedia Inc. is a leader in breast imaging reporting and tracking solutions, providing innovative, cloud-based software designed to improve efficiency and accuracy in breast imaging. Founded by renowned breast radiologists, Ikonopedia is committed to enhancing patient care through state-of-the-art technology and a patient-centered approach. Learn more at www.ikonopedia.com.</p>
<div class="lb-trans"><p>Ikonopedia Inc.是乳腺影像报告和跟踪解决方案的领导者，提供创新的基于云的软件，旨在提高乳腺影像的效率和准确性。Ikonopedia 由著名的乳腺放射科医生创立，致力于通过先进的技术和以患者为中心的方法提升患者护理。了解更多信息，请访问 www.ikonopedia.com。</p>
</div><p>References:</p>
<div class="lb-trans"><p>参考文献：</p>
</div><ol>
<li>https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/cancer-facts/cancer-facts-for-women.html</li>
<li>Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751.</li>
<li>https://www.nationalbreastcancer.org/blog/tyrer-cuzick-model/</li>
</ol>
<div class="lb-trans"><ol>
<li>https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/cancer-facts/cancer-facts-for-women.html</li>
<li>Bray F 等。2022 年全球癌症统计：GLOBOCAN 对 185 个国家 36 种癌症的发病率和死亡率估计。CA Cancer J Clin. 2024 年 5-6 月;74(3):229-263. doi: 10.3322/caac.21834. Epub2024 年 4 月 4 日。PMID: 38572751。</li>
<li>https://www.nationalbreastcancer.org/blog/tyrer-cuzick-model/</li>
</ol>
</div><p>SOURCE Ikonopedia</p>
<div class="lb-trans"><p>来源 Ikonopedia</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REEyNjQ5NiZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcxNjIzUFJfTkVXU19VU1BSX19fX19EQTI2NDk2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DA26496&amp;Transmission_Id=202511171623PR_NEWS_USPR_____DA26496&amp;DateId=20251117"/></p>

Ikonopedia 扩大了 Risk Aware™ 的采用，因为放射科实践将主动乳腺癌风险评估作为优先事项